Journal of Feline Medicine and Surgery · 2015 · 26 citations · 18 references
Contrary to reports in the literature, FIMCTs seem to have an extremely variable biological behaviour. We propose a classification based on tumour degree of differentiation and proliferative activity. These findings need to be confirmed in larger series, and exploration of further genomic regions of KIT is warranted to clarify its role in the development and progression of these neoplasms.
18
Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · Clinical Cancer Research · 2009 · 416 citations · Full text
Michele Columbo, Edward M. Horowitz, Luís M. Botana et al. · The Journal of Immunology · 1992 · 303 citations · Full text
Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors
K. Hahn, G. Oglivie, Todd Rusk et al. · Journal of Veterinary Internal Medicine · 2008 · 281 citations · Full text
The c-kit receptor ligand functions as a mast cell chemoattractant
CJ Meininger, Hajime Yano, Robert Rottapel et al. · Blood · 1992 · 280 citations · Full text
The c-kit receptor ligand functions as a mast cell chemoattractant
CJ Meininger, Hajime Yano, Robert Rottapel et al. · Blood · 1992 · 219 citations · Full text